Skip to content

First Pharma OÜ

Registry code (registrikood) 11941125Private limited company (Osaühing)VAT EE101394327Activity (EMTAK 46461): Ravimite ja muude apteegikaupade hulgimüükActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€4.9M
▼ 13.1% vs 2024
Profit before tax (2025)
€192k
Employees, FTE (2025)
9
State taxes paid, last 4 quarters
€139k

Revenue, profit and employees, 2019–2025

€3.1M2019€4.6M2020€4.2M2021€5.1M2022€5.2M2023€5.6M2024€4.9M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€3,107,916€53,692€29,848€104,7655
2020€4,595,381€185,303€147,290€157,8696
2021€4,239,209€151,296€112,941€147,3787
2022€5,138,231€231,293€177,850€180,6987
2023€5,240,425€314,371€253,201€256,0497
2024€5,609,729€308,096€226,227€229,4909
2025€4,875,857€227,021€148,763€226,2539

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€4,328€464,818€360,053€0€104,765
2020€4,328€627,317€469,448€0€157,869
2021€4,328€707,779€528,680€31,721€147,378
2022€4,328€834,724€645,852€8,174€180,698
2023€4,328€914,992€658,943€0€256,049
2024€6,032€853,586€624,096—€229,490
2025€4,603€957,568€731,315—€226,253

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€7,933€28,524€1,745,0327
2022 Q2€42,369€31,508€2,161,8587
2022 Q3€23,121€32,660€2,311,8497
2022 Q4€276€27,963€2,334,5147
2023 Q1€27,372€30,872€1,838,2897
2023 Q2€20,541€27,535€1,685,8297
2023 Q3€7,617€31,791€2,527,5157
2023 Q4€42,558€33,731€2,414,2907
2024 Q1€47,705€39,729€2,364,7977
2024 Q2€60,533€47,559€2,568,8476
2024 Q3€42,006€48,068€1,811,8607
2024 Q4€46,466€49,916€1,949,9317
2025 Q1€55,967€53,887€1,932,9647
2025 Q2€41,359€55,070€1,863,6618
2025 Q3€42,585€50,718€2,103,0737
2025 Q4€12,197€45,852€2,033,0498
2026 Q1€42,017€48,886€2,210,3949
2026 Q2€46,003€48,953€2,243,8519
2026 Q3€38,892€54,062€1,467,6967

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), First Pharma OÜ reported revenue of €4,875,857.

The company closed the 2025 financial year with a net profit of €148,763.

Revenue decreased by 13.1% from €5,609,729 in 2024 to €4,875,857 in 2025.

Revenue grew at a compound annual rate of 7.8% between 2019 and 2025.

Equity accounted for 23.6% of total assets of €957,568 at the end of the 2025 reporting period.

With 9 full-time-equivalent employees in 2025, revenue per employee was €541,762.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, First Pharma OÜ reported €7,954,990 in turnover.

EMTA recorded 7 employees for the quarter ending Q3 2026, compared with 9 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.